These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4660395)

  • 41. [Serum glycoproteins in coronary arteriosclerosis].
    Panaitescu G; Fica V; Tone P; Olteanu D
    Med Interna (Bucur); 1973 Aug; 25(8):929-35. PubMed ID: 4793913
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of submaximal physical exertion on serum lipid levels and the blood coagulation and fibrinolysis systems in patients with arteriosclerosis].
    Markiewicz K; Cholewa M; Jazdzewski B; Gawor Z
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):857-61. PubMed ID: 6494044
    [No Abstract]   [Full Text] [Related]  

  • 43. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 44. Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?
    Ngaage DL; Schaff HV; Mullany CJ; Sundt TM; Dearani JA; Barnes S; Daly RC; Orszulak TA
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):182-9. PubMed ID: 17198809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Differential diagnosis of mitral defect of the heart and arteriosclerotic cardiosclerosis complicated by cardiac fibrillation].
    Tiurina AG
    Ter Arkh; 1971 Nov; 43(11):23-6. PubMed ID: 5149219
    [No Abstract]   [Full Text] [Related]  

  • 46. [Seasonal changes in the fibrinolytic system of the blood in patients with coronary arteriosclerosis].
    Semenko IF
    Klin Med (Mosk); 1973 Aug; 51(8):57-63. PubMed ID: 4754475
    [No Abstract]   [Full Text] [Related]  

  • 47. A study on the ballistocardiogram in auricular fibrillation by means of harmonic analysis.
    Sasaki K
    Jpn Circ J; 1971 Dec; 35(12):1595-603. PubMed ID: 5172479
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of cetamiphen on coagulative properties of blood in patients with coronary arteriosclerosis].
    Zelenskaia LM
    Vrach Delo; 1975 Jul; (7):68-70. PubMed ID: 1220236
    [No Abstract]   [Full Text] [Related]  

  • 49. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis.
    Atak R; Turhan H; Senen K; Yalta K; Ayaz S; Alyan O; Basar N; Demirkan D
    J Heart Valve Dis; 2004 Mar; 13(2):159-64. PubMed ID: 15086252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Personal studies of blood coagulation system in patients with arteriosclerosis].
    Zola-Sleczek E
    Pol Tyg Lek; 1970 Feb; 25(8):288-91. PubMed ID: 5417313
    [No Abstract]   [Full Text] [Related]  

  • 51. [Fibrinolysis incidence in arteriosclerosis-induced illnesses as well as in arteriosclerosis positive and negative syntropic diseases].
    Schulz FH; Bach G; Künzel A
    Dtsch Gesundheitsw; 1970 Apr; 25(15):682-4. PubMed ID: 5483709
    [No Abstract]   [Full Text] [Related]  

  • 52. [Preliminary clinical observations on the anti-arrhythmic action of a new beta-receptor blocking agent: propranolol].
    Cherchi A; Lixi M; Mazza B; Camoglio E
    Minerva Med; 1966 Jan; 57(9):317-27. PubMed ID: 5909139
    [No Abstract]   [Full Text] [Related]  

  • 53. [Efficacy of blood coagulation tests in atherosclerosis with chronic cerebrovascular insufficiency].
    Mitsenko MD
    Lab Delo; 1982; (4):225-8. PubMed ID: 6177908
    [No Abstract]   [Full Text] [Related]  

  • 54. [Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
    Pellegrino L; Prencipe D
    Usp Sovrem Biol; 1973; 76(4):827-32. PubMed ID: 4793143
    [No Abstract]   [Full Text] [Related]  

  • 55. A probabilistic study of the irregularity of R-R interval durations in atrial fibrillation--a preliminary report.
    Hashida E; Inoue T; Yoshitani N; Tasaki T
    Jpn Circ J; 1973 Dec; 37(12):1423-6. PubMed ID: 4801913
    [No Abstract]   [Full Text] [Related]  

  • 56. [Compensatory possibilities of the anticoagulation system in patients with atherosclerotic cardiosclerosis].
    Shpirt EIa; Krasavina TS
    Klin Med (Mosk); 1974 Jan; 52(1):64-70. PubMed ID: 4466889
    [No Abstract]   [Full Text] [Related]  

  • 57. [Compensatory reserves of the blood coagulation system in cardiosclerosis].
    Shpurt EI
    Sov Med; 1976 Jan; (1):18-24. PubMed ID: 942542
    [No Abstract]   [Full Text] [Related]  

  • 58. [Functional state of the coagulating and fibrinolytic systems of blood in patients with marked arteriosclerosis of the coronary arteries].
    Shchigel'skiĭ VI
    Kardiologiia; 1974; 15(3):54-9. PubMed ID: 4838736
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of treatment of atherosclerosis with Bogomolets' serum on the indicators of blood coagulation].
    Miagkaia IP; Mkhitarian LS; Lipkan GN
    Klin Med (Mosk); 1975 Aug; 53(8):132-8. PubMed ID: 52737
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathogenesis of blood coagulation disorders in coronary arteriosclerosis].
    Ermolaev VV; Sytnikova IA
    Kardiologiia; 1978 Oct; 18(10):132-3. PubMed ID: 713245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.